Combining Carina’s advanced CAR-T platform technologies with AdAlta’s i-body targeting capability, the collaboration aims to create unique, next-generation bi-specific CAR-T cells. AdAlta Limited...
The SHREAD gene therapy platform, which allows the body to generate therapeutic agents on demand at precise locations, is expected to reduce the side effects of anti-cancer treatments and facilitate...
Researchers led by Katsunori Tanaka and Kenward Vong at the RIKEN Cluster for Pioneering Research (CPR) in Japan have demonstrated that tumour growth can be reduced by therapy that tags cancer cells...
